The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InCornerstone Investment Partners LLC has initiated a significant new position in Thermo Fisher Scientific Inc. (TMO), purchasing over 85,000 shares. The investment, valued at approximately $41.39 million, aligns with recent portfolio adjustments by other major institutions like Vanguard and Norges Bank. This move follows the company's authorization of a massive $5 billion share buyback program, triggered by positive quarterly earnings results. Market analysts currently maintain a "Moderate Buy" rating on the stock, reflecting sustained institutional confidence in the healthcare giant. The average price target for TMO stands at $633.68, suggesting further upside potential from current levels. Despite some recent insider selling, the combination of large-scale buybacks and institutional backing provides a strong support level for the stock.